A case of cutaneous melanoma metastatic to the ciliary body and choroid with complete regression via systemic dual checkpoint inhibitor therapy
Abstract Background Cutaneous melanoma is the leading cause of death from cutaneous malignancy and tends to metastasize lymphatically and hematogenously to the lung, liver, brain, and bone; it is a rare source of metastatic disease to the eye. Herein we provide a case report of cutaneous melanoma me...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-01-01
|
| Series: | BMC Ophthalmology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12886-025-03847-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841544880104407040 |
|---|---|
| author | Ansam I. Qaddoumi William I. Evans Matthew W. Wilson |
| author_facet | Ansam I. Qaddoumi William I. Evans Matthew W. Wilson |
| author_sort | Ansam I. Qaddoumi |
| collection | DOAJ |
| description | Abstract Background Cutaneous melanoma is the leading cause of death from cutaneous malignancy and tends to metastasize lymphatically and hematogenously to the lung, liver, brain, and bone; it is a rare source of metastatic disease to the eye. Herein we provide a case report of cutaneous melanoma metastatic to the ciliary body and choroid involving clinical examination, slit lamp photography, and B-scan ultrasonography. Result A 55-year-old female with known metastatic cutaneous melanoma presented with pain, a large ciliochoroidal mass, visual decline, and diffuse intraocular inflammation. The examination and testing were consistent with intraocular metastasis from her primary cutaneous melanoma. Given the extent of intraocular disease, the patient elected for enucleation of the involved eye. The patient’s intraocular disease demonstrated significant regression on combination immunotherapy with nivolumab and ipilimumab and surgery was subsequently deferred. The metastatic ciliochoroidal lesion ultimately regressed completely with systemic dual checkpoint inhibitor therapy. Conclusion Combination therapy with ipilimumab and nivolumab immunotherapy may be effective in the treatment of aggressive intraocular metastatic cutaneous melanoma. |
| format | Article |
| id | doaj-art-3423b71288574087bdebc6194725c541 |
| institution | Kabale University |
| issn | 1471-2415 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Ophthalmology |
| spelling | doaj-art-3423b71288574087bdebc6194725c5412025-01-12T12:12:26ZengBMCBMC Ophthalmology1471-24152025-01-012511510.1186/s12886-025-03847-wA case of cutaneous melanoma metastatic to the ciliary body and choroid with complete regression via systemic dual checkpoint inhibitor therapyAnsam I. Qaddoumi0William I. Evans1Matthew W. Wilson2Quillen College of Medicine, East Tennessee State UniversityDepartment of Surgery, St. Jude Children’s Research HospitalDepartment of Surgery, St. Jude Children’s Research HospitalAbstract Background Cutaneous melanoma is the leading cause of death from cutaneous malignancy and tends to metastasize lymphatically and hematogenously to the lung, liver, brain, and bone; it is a rare source of metastatic disease to the eye. Herein we provide a case report of cutaneous melanoma metastatic to the ciliary body and choroid involving clinical examination, slit lamp photography, and B-scan ultrasonography. Result A 55-year-old female with known metastatic cutaneous melanoma presented with pain, a large ciliochoroidal mass, visual decline, and diffuse intraocular inflammation. The examination and testing were consistent with intraocular metastasis from her primary cutaneous melanoma. Given the extent of intraocular disease, the patient elected for enucleation of the involved eye. The patient’s intraocular disease demonstrated significant regression on combination immunotherapy with nivolumab and ipilimumab and surgery was subsequently deferred. The metastatic ciliochoroidal lesion ultimately regressed completely with systemic dual checkpoint inhibitor therapy. Conclusion Combination therapy with ipilimumab and nivolumab immunotherapy may be effective in the treatment of aggressive intraocular metastatic cutaneous melanoma.https://doi.org/10.1186/s12886-025-03847-wCiliary bodyImmunotherapyMelanomaMetastasisRegression |
| spellingShingle | Ansam I. Qaddoumi William I. Evans Matthew W. Wilson A case of cutaneous melanoma metastatic to the ciliary body and choroid with complete regression via systemic dual checkpoint inhibitor therapy BMC Ophthalmology Ciliary body Immunotherapy Melanoma Metastasis Regression |
| title | A case of cutaneous melanoma metastatic to the ciliary body and choroid with complete regression via systemic dual checkpoint inhibitor therapy |
| title_full | A case of cutaneous melanoma metastatic to the ciliary body and choroid with complete regression via systemic dual checkpoint inhibitor therapy |
| title_fullStr | A case of cutaneous melanoma metastatic to the ciliary body and choroid with complete regression via systemic dual checkpoint inhibitor therapy |
| title_full_unstemmed | A case of cutaneous melanoma metastatic to the ciliary body and choroid with complete regression via systemic dual checkpoint inhibitor therapy |
| title_short | A case of cutaneous melanoma metastatic to the ciliary body and choroid with complete regression via systemic dual checkpoint inhibitor therapy |
| title_sort | case of cutaneous melanoma metastatic to the ciliary body and choroid with complete regression via systemic dual checkpoint inhibitor therapy |
| topic | Ciliary body Immunotherapy Melanoma Metastasis Regression |
| url | https://doi.org/10.1186/s12886-025-03847-w |
| work_keys_str_mv | AT ansamiqaddoumi acaseofcutaneousmelanomametastatictotheciliarybodyandchoroidwithcompleteregressionviasystemicdualcheckpointinhibitortherapy AT williamievans acaseofcutaneousmelanomametastatictotheciliarybodyandchoroidwithcompleteregressionviasystemicdualcheckpointinhibitortherapy AT matthewwwilson acaseofcutaneousmelanomametastatictotheciliarybodyandchoroidwithcompleteregressionviasystemicdualcheckpointinhibitortherapy AT ansamiqaddoumi caseofcutaneousmelanomametastatictotheciliarybodyandchoroidwithcompleteregressionviasystemicdualcheckpointinhibitortherapy AT williamievans caseofcutaneousmelanomametastatictotheciliarybodyandchoroidwithcompleteregressionviasystemicdualcheckpointinhibitortherapy AT matthewwwilson caseofcutaneousmelanomametastatictotheciliarybodyandchoroidwithcompleteregressionviasystemicdualcheckpointinhibitortherapy |